Trial Profile
The six months study of unoprostone eye drop therapy for retinitis pigmentosa
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Unoprostone (Primary)
- Indications Retinitis pigmentosa
- Focus Therapeutic Use
- 20 Jan 2014 New trial record
- 23 Oct 2013 2-year results of this study have been presented at the International Society for Clinical Electrophysiology of Vision 2013, according to a R Tech Ueno media release.